MedPath

Single Center Observational Study to Evaluate the Clinical Outcome of Patients with Bioabsorbable Vascular Scaffold (BVS, ABSORB® Abbot Vascular) after standard PCI Procedure.

Conditions
I20-I25
Ischaemic heart diseases
Registration Number
DRKS00019947
Lead Sponsor
Hegau-Bodensee Kliniken Singen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Enrolling by invitation
Sex
All
Target Recruitment
150
Inclusion Criteria

(1) Patient received a BVS at the Hegau-Bodensee Clinic between 2013 and 2017, (2) Signed informed consent and privacy policy

Exclusion Criteria

(1) Patient age < 18 years, (2) Patient is not able to write and understand German

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
combined endpoint of Cardiac Death (CD), Myocardial Infarction (MI), Target Lesion Revascularization (TLR), Target Vessel Revascularization (TVR), Stent Thrombosis (ST)
Secondary Outcome Measures
NameTimeMethod
Quality of life measured by EQ-5D-5
© Copyright 2025. All Rights Reserved by MedPath